Literature DB >> 19402665

Rhodamine inhibitors of P-glycoprotein: an amide/thioamide "switch" for ATPase activity.

Michael K Gannon1, Jason J Holt, Stephanie M Bennett, Bryan R Wetzel, Tip W Loo, M Claire Bartlett, David M Clarke, Geri A Sawada, J William Higgins, Gregory Tombline, Thomas J Raub, Michael R Detty.   

Abstract

We have examined 46 tetramethylrosamine/rhodamine derivatives with structural diversity in the heteroatom of the xanthylium core, the amino substituents of the 3- and 6-positions, and the alkyl, aryl, or heteroaryl group at the 9-substituent. These compounds were examined for affinity and ATPase stimulation in isolated MDR3 CL P-gp and human P-gp-His(10), for their ability to promote uptake of calcein AM and vinblastine in multidrug-resistant MDCKII-MDR1 cells, and for transport in monolayers of MDCKII-MDR1 cells. Thioamide 31-S gave K(M) of 0.087 microM in human P-gp. Small changes in structure among this set of compounds affected affinity as well as transport rate (or flux) even though all derivatives examined were substrates for P-gp. With isolated protein, tertiary amide groups dictate high affinity and high stimulation while tertiary thioamide groups give high affinity and inhibition of ATPase activity. In MDCKII-MDR1 cells, the tertiary thioamide-containing derivatives promote uptake of calcein AM and have very slow passive, absorptive, and secretory rates of transport relative to transport rates for tertiary amide-containing derivatives. Thioamide 31-S promoted uptake of calcein AM and inhibited efflux of vinblastine with IC(50)'s of approximately 2 microM in MDCKII-MDR1 cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19402665      PMCID: PMC3400110          DOI: 10.1021/jm900253g

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  64 in total

1.  Structure-function relationships of multidrug resistance P-glycoprotein.

Authors:  Ilza K Pajeva; Christoph Globisch; Michael Wiese
Journal:  J Med Chem       Date:  2004-05-06       Impact factor: 7.446

Review 2.  The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research.

Authors:  Michael M Gottesman; Victor Ling
Journal:  FEBS Lett       Date:  2005-12-28       Impact factor: 4.124

3.  P-glycoprotein. Associations between domains and between domains and molecular chaperones.

Authors:  T W Loo; D M Clarke
Journal:  J Biol Chem       Date:  1995-09-15       Impact factor: 5.157

4.  Computational models for identifying potential P-glycoprotein substrates and inhibitors.

Authors:  Patrizia Crivori; Benedetta Reinach; Daniele Pezzetta; Italo Poggesi
Journal:  Mol Pharm       Date:  2006 Jan-Feb       Impact factor: 4.939

5.  Drug transport by reconstituted P-glycoprotein in proteoliposomes. Effect of substrates and modulators, and dependence on bilayer phase state.

Authors:  P Lu; R Liu; F J Sharom
Journal:  Eur J Biochem       Date:  2001-03

6.  Do drug substrates enter the common drug-binding pocket of P-glycoprotein through "gates"?

Authors:  Tip W Loo; David M Clarke
Journal:  Biochem Biophys Res Commun       Date:  2005-04-08       Impact factor: 3.575

7.  Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein.

Authors:  S Dey; M Ramachandra; I Pastan; M M Gottesman; S V Ambudkar
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

Review 8.  Targeting multidrug resistance in cancer.

Authors:  Gergely Szakács; Jill K Paterson; Joseph A Ludwig; Catherine Booth-Genthe; Michael M Gottesman
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

9.  P-glycoprotein senses its substrates and the lateral membrane packing density: consequences for the catalytic cycle.

Authors:  Päivi Aänismaa; Ewa Gatlik-Landwojtowicz; Anna Seelig
Journal:  Biochemistry       Date:  2008-08-30       Impact factor: 3.162

10.  QacR-cation recognition is mediated by a redundancy of residues capable of charge neutralization.

Authors:  Kate M Peters; Jason T Schuman; Ronald A Skurray; Melissa H Brown; Richard G Brennan; Maria A Schumacher
Journal:  Biochemistry       Date:  2008-07-11       Impact factor: 3.162

View more
  18 in total

1.  P-glycoprotein-ATPase modulation: the molecular mechanisms.

Authors:  Xiaochun Li-Blatter; Andreas Beck; Anna Seelig
Journal:  Biophys J       Date:  2012-03-20       Impact factor: 4.033

2.  Thiorhodamines containing amide and thioamide functionality as inhibitors of the ATP-binding cassette drug transporter P-glycoprotein (ABCB1).

Authors:  Alexandra Orchard; Gregory A Schamerhorn; Brandon D Calitree; Geri A Sawada; Tip W Loo; M Claire Bartlett; David M Clarke; Michael R Detty
Journal:  Bioorg Med Chem       Date:  2012-06-07       Impact factor: 3.641

3.  Selective photodepletion of malignant T cells in extracorporeal photopheresis with selenorhodamine photosensitizers.

Authors:  Zachariah A McIver; Mark W Kryman; Young Choi; Benjamin N Coe; Gregory A Schamerhorn; Michelle K Linder; Kellie S Davies; Jacqueline E Hill; Geri A Sawada; Jason M Grayson; Michael R Detty
Journal:  Bioorg Med Chem       Date:  2016-06-02       Impact factor: 3.641

Review 4.  Disruption of small molecule transporter systems by Transporter-Interfering Chemicals (TICs).

Authors:  Sascha C T Nicklisch; Amro Hamdoun
Journal:  FEBS Lett       Date:  2020-12-09       Impact factor: 4.124

5.  P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia.

Authors:  Gwen McCaffrey; William D Staatz; Lucy Sanchez-Covarrubias; Jessica D Finch; Kristen Demarco; Mei-Li Laracuente; Patrick T Ronaldson; Thomas P Davis
Journal:  J Neurochem       Date:  2012-07-10       Impact factor: 5.372

6.  Identification of the distance between the homologous halves of P-glycoprotein that triggers the high/low ATPase activity switch.

Authors:  Tip W Loo; David M Clarke
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

7.  Chalcogenopyrylium dyes as differential modulators of organic anion transport by multidrug resistance protein 1 (MRP1), MRP2, and MRP4.

Authors:  Robert L Myette; Gwenaëlle Conseil; Sean P Ebert; Bryan Wetzel; Michael R Detty; Susan P C Cole
Journal:  Drug Metab Dispos       Date:  2013-03-25       Impact factor: 3.922

8.  Biomimetic Design of Protein Nanomaterials for Hydrophobic Molecular Transport.

Authors:  Dongmei Ren; Mercè Dalmau; Arlo Randall; Matthew M Shindel; Pierre Baldi; Szu-Wen Wang
Journal:  Adv Funct Mater       Date:  2012-04-23       Impact factor: 18.808

9.  Targeting T Cell Bioenergetics by Modulating P-Glycoprotein Selectively Depletes Alloreactive T Cells To Prevent Graft-versus-Host Disease.

Authors:  Zachariah A McIver; Jason M Grayson; Benjamin N Coe; Jacqueline E Hill; Gregory A Schamerhorn; Tymish Y Ohulchanskyy; Michelle K Linder; Kellie S Davies; Roy S Weiner; Michael R Detty
Journal:  J Immunol       Date:  2016-07-25       Impact factor: 5.422

10.  Cysteines introduced into extracellular loops 1 and 4 of human P-glycoprotein that are close only in the open conformation spontaneously form a disulfide bond that inhibits drug efflux and ATPase activity.

Authors:  Tip W Loo; David M Clarke
Journal:  J Biol Chem       Date:  2014-07-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.